These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 36129262)
41. Targeting Drug-Sensitive and -Resistant Strains of Mycobacterium tuberculosis by Inhibition of Src Family Kinases Lowers Disease Burden and Pathology. Chandra P; Rajmani RS; Verma G; Bhavesh NS; Kumar D mSphere; 2016; 1(2):. PubMed ID: 27303736 [TBL] [Abstract][Full Text] [Related]
42. Reversing BCG-mediated autophagy inhibition and mycobacterial survival to improve vaccine efficacy. Gonzalez-Orozco M; Strong EJ; Paroha R; Lee S BMC Immunol; 2022 Sep; 23(1):43. PubMed ID: 36104771 [TBL] [Abstract][Full Text] [Related]
43. Autophagy: A new strategy for host-directed therapy of tuberculosis. Paik S; Kim JK; Chung C; Jo EK Virulence; 2019 Dec; 10(1):448-459. PubMed ID: 30322337 [TBL] [Abstract][Full Text] [Related]
44. Targeting the human macrophage with combinations of drugs and inhibitors of Ca2+ and K+ transport to enhance the killing of intracellular multi-drug resistant Mycobacterium tuberculosis (MDR-TB)--a novel, patentable approach to limit the emergence of XDR-TB. Martins M Recent Pat Antiinfect Drug Discov; 2011 May; 6(2):110-7. PubMed ID: 21517742 [TBL] [Abstract][Full Text] [Related]
45. New Verapamil Analogs Inhibit Intracellular Mycobacteria without Affecting the Functions of Mycobacterium-Specific T Cells. Abate G; Ruminiski PG; Kumar M; Singh K; Hamzabegovic F; Hoft DF; Eickhoff CS; Selimovic A; Campbell M; Chibale K Antimicrob Agents Chemother; 2015 Dec; 60(3):1216-25. PubMed ID: 26643325 [TBL] [Abstract][Full Text] [Related]
46. Bfl-1/A1 acts as a negative regulator of autophagy in mycobacteria infected macrophages. Kathania M; Raje CI; Raje M; Dutta RK; Majumdar S Int J Biochem Cell Biol; 2011 Apr; 43(4):573-85. PubMed ID: 21167304 [TBL] [Abstract][Full Text] [Related]
47. Effect of Mycobacterium tuberculosis Enhancement of Macrophage P-Glycoprotein Expression and Activity on Intracellular Survival During Antituberculosis Drug Treatment. Wu Q; Hossfeld A; Gerberick A; Saljoughian N; Tiwari C; Mehra S; Ganesan LP; Wozniak DJ; Rajaram MVS J Infect Dis; 2019 Nov; 220(12):1989-1998. PubMed ID: 31412123 [TBL] [Abstract][Full Text] [Related]
48. Nilotinib: A Tyrosine Kinase Inhibitor Mediates Resistance to Intracellular Mycobacterium Via Regulating Autophagy. Hussain T; Zhao D; Shah SZA; Sabir N; Wang J; Liao Y; Song Y; Dong H; Hussain Mangi M; Ni J; Yang L; Zhou X Cells; 2019 May; 8(5):. PubMed ID: 31130711 [TBL] [Abstract][Full Text] [Related]
49. Novel Function of Cyclooxygenase-2: Suppressing Mycobacteria by Promoting Autophagy via the Protein Kinase B/Mammalian Target of Rapamycin Pathway. Xiong W; Wen Q; Du X; Wang J; He W; Wang R; Hu S; Zhou X; Yang J; Gao Y; Ma L J Infect Dis; 2018 Mar; 217(8):1267-1279. PubMed ID: 29373690 [TBL] [Abstract][Full Text] [Related]
50. TWEAK-Fn14 Axis Induces Calcium-Associated Autophagy and Cell Death To Control Mycobacterial Survival in Macrophages. Chen YM; Liu PY; Tang KT; Liu HJ; Liao TL Microbiol Spectr; 2022 Dec; 10(6):e0317222. PubMed ID: 36321903 [TBL] [Abstract][Full Text] [Related]
51. Pasakbumin A controls the growth of Mycobacterium tuberculosis by enhancing the autophagy and production of antibacterial mediators in mouse macrophages. Lee HJ; Ko HJ; Kim SH; Jung YJ PLoS One; 2019; 14(3):e0199799. PubMed ID: 30865638 [TBL] [Abstract][Full Text] [Related]
52. microRNA-20a Inhibits Autophagic Process by Targeting ATG7 and ATG16L1 and Favors Mycobacterial Survival in Macrophage Cells. Guo L; Zhao J; Qu Y; Yin R; Gao Q; Ding S; Zhang Y; Wei J; Xu G Front Cell Infect Microbiol; 2016; 6():134. PubMed ID: 27803889 [TBL] [Abstract][Full Text] [Related]
53. MicroRNA-106a Inhibits Autophagy Process and Antimicrobial Responses by Targeting ULK1, ATG7, and ATG16L1 During Mycobacterial Infection. Liu K; Hong D; Zhang F; Li X; He M; Han X; Zhang G; Xu G; Stonehouse NJ; Jiang Z; An W; Guo L Front Immunol; 2020; 11():610021. PubMed ID: 33505399 [TBL] [Abstract][Full Text] [Related]
54. Allicin enhances antimicrobial activity of macrophages during Mycobacterium tuberculosis infection. Dwivedi VP; Bhattacharya D; Singh M; Bhaskar A; Kumar S; Fatima S; Sobia P; Kaer LV; Das G J Ethnopharmacol; 2019 Oct; 243():111634. PubMed ID: 30537531 [TBL] [Abstract][Full Text] [Related]
55. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
56. Interferon regulatory factor 1 eliminates mycobacteria by suppressing p70 S6 kinase via mechanistic target of rapamycin signaling. Zhou X; Yang J; Zhang Z; Zhang L; Lie L; Zhu B; Xu L; Gao Y; Du X; Huang Y; Wang R; Liu H; Li Y; Hu S; Zhou C; Wen Q; Pan Q; Ma L J Infect; 2019 Sep; 79(3):262-276. PubMed ID: 31226272 [TBL] [Abstract][Full Text] [Related]
58. Thymoquinone (TQ) inhibits the replication of intracellular Mycobacterium tuberculosis in macrophages and modulates nitric oxide production. Mahmud HA; Seo H; Kim S; Islam MI; Nam KW; Cho HD; Song HY BMC Complement Altern Med; 2017 May; 17(1):279. PubMed ID: 28545436 [TBL] [Abstract][Full Text] [Related]
59. Nanomaterial-mediated host directed therapy of tuberculosis by manipulating macrophage autophagy. Liu Y; Wang J; Yang J; Xia J; Yu J; Chen D; Huang Y; Yang F; Ruan Y; Xu JF; Pi J J Nanobiotechnology; 2024 Oct; 22(1):608. PubMed ID: 39379986 [TBL] [Abstract][Full Text] [Related]
60. Targeting Autophagy as a Strategy for Developing New Vaccines and Host-Directed Therapeutics Against Mycobacteria. Strong EJ; Lee S Front Microbiol; 2020; 11():614313. PubMed ID: 33519771 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]